Our People

Our team has an enviable combination of skills and expertise from across the marine, biomedical, commercial and scientific sectors with a passion for converging the most advanced research concepts for better patient care.

Ronnie Robins, Chairman and Co-Founder

Our Chairman and Co-Founder, Ronnie Invested in the Inagh Valley site where Zoan BioMed is located. His aim was and remains today, to establish an enterprise community in Connemara that would preserve and enhance the pristine environment in the shelter of the Atlantic – while offering an invaluable source of employment in the region. Ronnie was a highly successful Irish Barrister, elected Senior Counsel.

Stephen Wann, CEO

Stephen is CEO of Zoan and was an early investor in the business. Sharing the business ambitions to innovate in the Orthopaedic industry, he recognised the enormous opportunity to deliver improved patient outcomes with Zoan’s unique platform. Stephen brings operational and leadership experience across many markets and industries.  He has 20+ years experience in the US, Europe and Asia holding senior positions with General Electric, Lloyds Banking Group and HSBC and has worked extensively with private equity partners and investors. Stephen graduated from Trinity College in Business & Economics and graduated as a Chartered Accountant with KPMG.

James Martin, Production Director

18 years experience of designing, creating and commercialising coral mesocosms. James is instrumental in the transition from a theory-based concept, into the creation of a scalable unit based operations under medical device standards. His developed processes are recognised across the academic landscape and are the foundation of Zoan’s IP.

Declan Clarke, Co-Founder

Co-Founder of Zoan BioMed with a passion for commercialising innovative medical device research. Declan holds an MSc in Marine Science and spent a number of years advising the National Centre for Biomedical Engineering Science on commercialisation strategies.

Paul Burke, Director Regulation & Network

Leads the strategic partnership with PBC Biomed Ltd. Paul has extensive experience in bringing orthobiologic products through the product lifecycle to Regulatory Approval and has an extensive network of clinicians and key influencers. Paul successfully managed the spin-out of CelgenTek which was acquired by ZimmerBiomet. CelgenTek developed, manufactured and commercialised innovative orthobiologics for treating compromised bone. Paul has a B.Sc. Biochemistry, University of Limerick, Ireland.

Dr Cynthia Coleman, Scientific Advisor

Lecturer in Cellular Manufacturing & Therapy at the National University of Ireland Galway.  She has significant experience in creating, evaluating, patenting and translating cellular therapies and medical devices in enterprise and academic settings. Experience includes Johnson & Johnson and collaborations with Medtronic, Smith & Nephew, Orbsen Therapeutics, Owl Biomedical and Galway University Hospitals. Cynthia has contributed to clinical trials in Ireland, Germany, the US and Denmark, secured patents and developed an extensive publication record in orthopaedic repair.

Michael Wann, Commercial Director

A qualified accountant with KPMG holding a BSc in Business & Economics from Trinity College, Dublin. Michael is involved in many businesses providing finance and sitting on a number of boards in executive and non-executive roles. His business interests include renewable energy, civil construction and property development. Michael is a shareholder and Director in a number of bio med companies.

Flora Joyce, Scientific Officer

Flora brings a wealth of experience from her diverse background spanning research, academic teaching and most recently clinical work as a practising pharmacist and member of the Pharmaceutical Society of Ireland. Flora completed her B.Sc (Hons) in Biotechnology and M.Sc in Neuropharmacology at NUI, Galway. As part of her M.Sc studies she worked in London for GSK, developing a model for Alzheimer’s. She went on to spend two years lecturing in pharmacology and neuropharmacology. Flora undertook prize winning research, presenting a systematic review of the literature around Ankylosing Spondylitis and co-ordinated an audit of patient clinical data in Scotland and Ireland.

Helen Johnson, Director Legal

Barrister at Law (2000) and a European Trade Mark and Design Attorney, specialising in contentious and non-contentious intellectual property matters and commercial law. Helen is the author of a textbook and several articles on IP and, as well as lecturing and tutoring, she has co-developed IP courses for the Law Society of Ireland in addition to other third level legal courses. She also specialises in animal health and welfare law and prosecutes breaches of the legislation before the Irish courts.

Contact Us

To find out more about Zoan BioMed get in touch